134 related articles for article (PubMed ID: 15350383)
1. Anastrozole, an aromatase inhibitor, and medroxyprogesterone acetate therapy in premenopausal obese women with endometrial cancer: a report of two cases successfully treated without hysterectomy.
Burnett AF; Bahador A; Amezcua C
Gynecol Oncol; 2004 Sep; 94(3):832-4. PubMed ID: 15350383
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor.
Shippen ER; West WJ
Fertil Steril; 2004 May; 81(5):1395-8. PubMed ID: 15136110
[TBL] [Abstract][Full Text] [Related]
3. Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor.
Leiser AL; Hamid AM; Blanchard R
Gynecol Oncol; 2004 Aug; 94(2):567-71. PubMed ID: 15297205
[TBL] [Abstract][Full Text] [Related]
4. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK
Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
[TBL] [Abstract][Full Text] [Related]
5. Treatment with medroxyprogesterone acetate plus levonorgestrel-releasing intrauterine system for early-stage endometrial cancer in young women: single-arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2009).
Kim MK; Seong SJ; Lee TS; Kim JW; Nam BH; Hong SR; Suh KS
Jpn J Clin Oncol; 2012 Dec; 42(12):1215-8. PubMed ID: 23071290
[TBL] [Abstract][Full Text] [Related]
6. Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.
Yu M; Yang JX; Wu M; Lang JH; Huo Z; Shen K
Fertil Steril; 2009 Dec; 92(6):2122-4. PubMed ID: 19591991
[TBL] [Abstract][Full Text] [Related]
7. Resolution of endometrial hyperplasia with adjuvant anastrozole treatment in postmenopausal breast cancer: a case report.
Stilwill SE; Cooper BC
J Reprod Med; 2007 Oct; 52(10):979-80. PubMed ID: 17977182
[TBL] [Abstract][Full Text] [Related]
8. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: Hormonal therapy, chemotherapy and molecularly targeted therapies.
Gadducci A; Cosio S; Genazzani AR
Crit Rev Oncol Hematol; 2006 Jun; 58(3):242-56. PubMed ID: 16436330
[TBL] [Abstract][Full Text] [Related]
9. Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report.
Shoji K; Oda K; Nakagawa S; Kawana K; Yasugi T; Ikeda Y; Takazawa Y; Kozuma S; Taketani Y
Med Oncol; 2011 Sep; 28(3):771-4. PubMed ID: 20354812
[TBL] [Abstract][Full Text] [Related]
10. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR
Hum Reprod; 2006 Feb; 21(2):545-53. PubMed ID: 16210385
[TBL] [Abstract][Full Text] [Related]
11. [Postoperative hormone (endocrine) therapy in endometrial carcinoma].
Hiura M; Oshita T; Nogawa T; Yokoyama T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():381-5. PubMed ID: 15535272
[No Abstract] [Full Text] [Related]
12. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
Ramirez PT; Frumovitz M; Bodurka DC; Sun CC; Levenback C
Gynecol Oncol; 2004 Oct; 95(1):133-8. PubMed ID: 15385122
[TBL] [Abstract][Full Text] [Related]
13. Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study.
Singh M; Zaino RJ; Filiaci VJ; Leslie KK
Gynecol Oncol; 2007 Aug; 106(2):325-33. PubMed ID: 17532033
[TBL] [Abstract][Full Text] [Related]
14. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
Hurst SA; Hartzfeld KM; Del Priore G
Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
[TBL] [Abstract][Full Text] [Related]
15. Progestogen treatment options for early endometrial cancer.
Cade TJ; Quinn MA; Rome RM; Neesham D
BJOG; 2010 Jun; 117(7):879-84. PubMed ID: 20394609
[TBL] [Abstract][Full Text] [Related]
16. Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study.
Kaufmann M; Jonat W; Hilfrich J; Eidtmann H; Gademann G; Zuna I; von Minckwitz G
J Clin Oncol; 2007 Jul; 25(19):2664-70. PubMed ID: 17563395
[TBL] [Abstract][Full Text] [Related]
17. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
[TBL] [Abstract][Full Text] [Related]
18. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate.
Mitsushita J; Toki T; Kato K; Fujii S; Konishi I
Gynecol Oncol; 2000 Oct; 79(1):129-32. PubMed ID: 11006045
[TBL] [Abstract][Full Text] [Related]
19. Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma.
Giannopoulos T; Butler-Manuel S; Tailor A
Gynecol Oncol; 2004 Dec; 95(3):762-4. PubMed ID: 15582001
[TBL] [Abstract][Full Text] [Related]
20. Outcome of fertility-preserving treatment in young women with endometrial carcinomas.
Niwa K; Tagami K; Lian Z; Onogi K; Mori H; Tamaya T
BJOG; 2005 Mar; 112(3):317-20. PubMed ID: 15713146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
